Clearside Biomedical (STU:CLM0) Institutional Ownership: 0.10% (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CLM0 Clearside Biomedical Inc STU:CLM0
44 GF Score
Price €4.35
GF Value €110.06
! 7 Warning Signs
View Full Analysis

What is Clearside Biomedical Institutional Ownership?

Clearside Biomedical STU:CLM0 44 Institutional Ownership is 0.10% as of Aug. 05, 2026. GuruFocus rates STU:CLM0 with a GF Score™ of 44/100 and a GF Value™ of €110.06. The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Clearside Biomedical's institutional ownership is 0.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Clearside Biomedical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Clearside Biomedical's Float Percentage Of Total Shares Outstanding is 98.33%.

Clearside Biomedical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Clearside Biomedical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearside Biomedical Institutional Ownership Chart

Clearside Biomedical Historical Data

The historical data trend for Clearside Biomedical can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 9.78 10.38 10.38 3.19 0.28 0.28 0.28 0.16 0.10 0.10
STU:CLM0
44GF Score
Clearside Biomedical Inc STU:CLM0
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clearside Biomedical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.10% mean?
Clearside Biomedical (STU:CLM0) has a Institutional Ownership of 0.10% as of Aug. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Clearside Biomedical and its competitors.
Is Clearside Biomedical's Institutional Ownership too high?
Clearside Biomedical's current Institutional Ownership is 0.10%. Overall, Clearside Biomedical has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Clearside Biomedical's Institutional Ownership compare to RMTG and ABPO?
Clearside Biomedical's Institutional Ownership of 0.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Clearside Biomedical and its competitors. Clearside Biomedical's current Institutional Ownership is 0.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearside Biomedical stock overvalued right now?
Clearside Biomedical (STU:CLM0) has a current Institutional Ownership of 0.10%. The stock's GF Value™ is €110.06, compared to a current price of €4.35 — trading 96% below its estimated fair value. The current Institutional Ownership is 0.10%. Clearside Biomedical's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Clearside Biomedical (STU:CLM0), the current Institutional Ownership is 0.10% as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clearside Biomedical (STU:CLM0) Overvalued in 2026?

Based on GuruFocus' analysis, Clearside Biomedical stock appears to be undervalued. The current stock price of €4.35 is trading 96% below its estimated GF Value™ of €110.06.

Key valuation signals for STU:CLM0:

  • Institutional Ownership: 0.10%
  • GF Value™: €110.06 vs. price of €4.35 (96% below fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the STU:CLM0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clearside Biomedical Business Description

Other Exchanges CLSDQ:USA
Address 900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
44GF Score

Get the complete analysis for STU:CLM0

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.35
Price
€110.06
GF Value